IL-9 as a Mediator of Th17-Driven Inflammatory Disease

Journal of Experimental Medicine - United States
doi 10.1084/jem.20090246
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Rockefeller University Press

Related search

Significance of Serum Il-9 Levels in Inflammatory Bowel Disease

International Journal of Immunopathology and Pharmacology
AllergyImmunologyPharmacology
2015English

Uric Acid-Driven Th17 Differentiation Requires Inflammasome-Derived IL-1 and IL-18

Journal of Immunology
AllergyImmunology
2011English

IL-15 Is an Inflammatory Mediator in the Tumor Microenvironment

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2015English

Inhaled IL-10 Suppresses Lung Tumorigenesis via Abrogation of Inflammatory Macrophage–Th17 Cell Axis

Journal of Immunology
AllergyImmunology
2018English

The Effects of Th17 Cytokines on the Inflammatory Mediator Production and Barrier Function of ARPE-19 Cells

PLoS ONE
Multidisciplinary
2011English

Plasticity of Th17 and Tregs and Its Clinical Importance as Therapeutic Target in Inflammatory Bowel Disease

Indian Journal of Inflammation Research
2018English

CD73 Is a Phenotypic Marker of Effector Memory Th17 Cells in Inflammatory Bowel Disease

European Journal of Immunology
AllergyImmunology
2012English

IL-36 Cytokines in Autoimmunity and Inflammatory Disease

Oncotarget
Oncology
2017English

CD96 Expression Determines the Inflammatory Potential of IL-9–producing Th9 Cells

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy